CBL (gene): Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 45: | Line 45: | ||
[[Category:Signal transduction]] | [[Category:Signal transduction]] | ||
[[Category:Ubiquitin-protein ligases]] | [[Category:Ubiquitin-protein ligases]] | ||
{{No image}} | |||
Revision as of 08:51, 10 February 2025
CBL (Casitas B-lineage Lymphoma) is a gene that encodes a member of the Cbl family of E3 ubiquitin-protein ligases. CBL proteins play a crucial role in cell signaling and cancer development.
Function
The CBL gene is involved in the intracellular signaling pathways of many cell surface receptors involved with cellular growth, differentiation, and apoptosis. These receptors include EGFR, PDGFR, and c-Met. The protein encoded by the CBL gene functions as a negative regulator of many signaling pathways that start from these cell surface receptors.
Clinical significance
Mutations in the CBL gene have been associated with Noonan syndrome and myeloproliferative disorder, both of which are conditions that affect multiple systems of the body.
Structure
The CBL protein has a modular structure consisting of an N-terminal tyrosine kinase binding (TKB) domain, a linker region, a RING finger domain, a proline-rich region, and a C-terminal ubiquitin-associated (UBA) domain.
Interactions
CBL has been shown to interact with:
See also
References
<references />
External links
| Genes on human chromosome 11 | ||||
|---|---|---|---|---|
This human genetics related article is a stub.
|
| Tyrosine kinase inhibitors | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This tyrosine kinase inhibitor related article is a stub.
|
| Ubiquitin-protein ligases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Ubiquitin-protein ligases related article is a stub.
|
